Charles River Laboratories International Inc (NYSE:CRL)
$ 214.2 25.52 (13.53%) Market Cap: 10.95 Bil Enterprise Value: 13.50 Bil PE Ratio: 25.59 PB Ratio: 2.97 GF Score: 87/100

Charles River Laboratories International Inc at Credit Suisse Healthcare Conference (Virtual) Transcript

Nov 10, 2020 / 03:15PM GMT
Release Date Price: $228.74 (-3.59%)
Erin Wright

Hi and welcome. This is Erin Wright, the life sciences, tools, diagnostics analyst at Crédit Suisse and welcome to our 2020 Crédit Suisse Health Care Conference. This year, we're obviously in a virtual format, so a little bit different. If you do have any questions, feel free to e-mail me at erin.wright@crédit.suisse.com and I'll be happy to relay questions to you -- to our presenters today.

Here with us, we have Charles River Laboratories. With them, we have Birgit Girshick -- I'm going to get your title right, I swear -- it's EVP, Discovery & Safety Assessment, Biologics Testing Solutions and Avian Vaccine Services, if I have it all there. So it's pretty hard-core at Charles River, it sounds like. But -- and we also have Todd Spencer, the IR maven himself on the line as well. And thank you, thank you so much for joining us today.

It's a fireside chat format, so we'll get started with Q&A right away here.

Questions & Answers

Erin Wright

I think one of the biggest question areas and one of the biggest, I guess, takeaways,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot